Article info
PDFNew directions
Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician
- Correspondence to Dr Peter J Angell, Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Tom Reilly Building, Byrom Street Campus, Liverpool L3 3AF, UK;P.Angell{at}2004.ljmu.ac.uk
Citation
Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician
Publication history
- Received March 20, 2012
- Accepted July 4, 2012
- First published October 24, 2012.
Online issue publication
October 11, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode